Grey Street Capital, LLC Novartis Ag Transaction History
Grey Street Capital, LLC
- $739 Billion
- Q1 2024
A detailed history of Grey Street Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Grey Street Capital, LLC holds 17,188 shares of NVS stock, worth $1.84 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
17,188Holding current value
$1.84 Million% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,432Shares Held
138MCall Options Held
1.48MPut Options Held
1.55M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.3 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$867 Million0.23% of portfolio
-
Morgan Stanley New York, NY7.42MShares$794 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.95MShares$637 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...